Currently out of the existing stock ratings of Kemp Dolliver, 2 are a BUY (100%).

Kemp Dolliver

Work Performance Price Targets & Ratings Chart

Analyst Kemp Dolliver works at BROOKLINE

Kemp Dolliver’s has documented 4 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ECOR, Electrocore LLC at 13-Jan-2023.

Wall Street Analyst Kemp Dolliver

Analyst best performing recommendations are on ECOR (ELECTROCORE LLC).
ECOR Electrocore LLC VRCA Verrica Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

15

$8.3 (123.88%)

11

1 months 6 days ago

1/7 (14.29%)

$7.77 (107.47%)

319

Buy

1.25

$-5.45 (-81.34%)

1 years 1 months 15 days ago

0/1 (0%)

$-3.28 (-72.41%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Kemp Dolliver?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?